Xylocard 500 500mg/5mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

xylocard 500 500mg/5ml injection ampoule

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 100 mg/ml - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections - indications as at 15 august 1996: cardiac arrhythmias. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

Xylocard 1000 1g/10mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

xylocard 1000 1g/10ml injection ampoule

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 100 mg/ml - injection, concentrated - excipient ingredients: water for injections; sodium hydroxide - indications as at 15 august 1996: cardiac arrhythmias. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

Xylocard 100 100mg/5mL injection ampoule kit Australia - English - Department of Health (Therapeutic Goods Administration)

xylocard 100 100mg/5ml injection ampoule kit

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide - indications as at 15 august 1996: cardiac arrhythmias. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

INVERTOSE 20% W/V I.V.infusion Egypt - English - EDA (Egyptian Drug Authority)

invertose 20% w/v i.v.infusion

el nasr - infusion - 20 %

INVERTOSE 20% W/V I.V.infusion Egypt - English - EDA (Egyptian Drug Authority)

invertose 20% w/v i.v.infusion

el nasr - infusion - 20 %

REMICARD INJECTION South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

remicard injection

adcock ingram limited - injection - see ingredients - each 1 ml solution contains lidocaine hydrochloride 100 mg

Xylocard Australia - English - Department of Health (Therapeutic Goods Administration)

xylocard

lignocaine hydrochloride anhydrous; lignocaine hydrochloride -

TRANEXAMIC ACID 500mg5mL INJECTION Bioindustria L.I.M. Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

tranexamic acid 500mg5ml injection bioindustria l.i.m.

mms pharma (malaysia) sdn. bhd. - tranexamic acid -

BAXTER POTASSIUM CHLORIDE 10 mmol and 0.29% SODIUM CHLORIDE 100 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 10 mmol and 0.29% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - sodium chloride, quantity: 2.92 g/l; potassium chloride, quantity: 7.46 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

SMOFKABIVEN amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 2463 mL Australia - English - Department of Health (Therapeutic Goods Administration)

smofkabiven amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 2463 ml

fresenius kabi australia pty ltd - medium chain triglycerides, quantity: 60 g/l; fish oil - rich in omega-3 acids, quantity: 30 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: sodium oleate; dl-alpha-tocopherol; glycerol; egg lecithin; water for injections; sodium hydroxide - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.